本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Acumen Pharmaceuticals, Inc.

1.58
-0.1500-8.67%
盤後1.600.0200+1.27%18:42 EST
成交量:25.96萬
成交額:41.28萬
市值:9,570.60萬
市盈率:-0.70
高:1.74
開:1.73
低:1.50
收:1.73
52周最高:2.62
52周最低:0.8551
股本:6,057.34萬
流通股本:3,292.95萬
量比:1.46
換手率:0.79%
股息:- -
股息率:- -
每股收益(TTM):-2.2658
每股收益(LYR):-1.7051
淨資產收益率:-85.93%
總資產收益率:-42.23%
市淨率:1.03
市盈率(LYR):-0.93

資料載入中...

公司資料

公司名字:
Acumen Pharmaceuticals, Inc.
交易所:
NASDAQ
成立時間:
1996
員工人數:
61
公司地址:
1210-1220 Washington St.,Suite 210,Newton,Massachusetts,United States
郵編:
02465
電話:
傳真:
- -
簡介:
Acumen Pharmaceuticals, Inc.於1996年在特拉華州註冊成立。該公司是一家臨床階段的生物製藥公司,正在開發一種新的疾病改善方法,以針對該公司認為是阿爾茨海默病或AD的關鍵根本原因。阿爾茨海默病是一種大腦進行性神經退行性疾病,會導致記憶和認知功能喪失,最終導致死亡。

董事

名稱
職位
Daniel O'Connell
Chief Executive Officer and Director
George Golumbeski
Chairman of the Board and Director
Derrell Porter
Independent Director
Jeffrey L. Ives
Independent Director
Kimberlee C. Drapki
Independent Director
Laura Stoppel
Independent Director
Nathan B. Fountain
Independent Director

股東

名稱
職位
Daniel O'Connell
Chief Executive Officer and Director
Russell Barton
Chief Operating Officer
Matthew Zuga
Chief Financial Officer and Chief Business Officer
Amy Schacterle
Chief Regulatory Officer, Head of Quality
Derek Meisner
Chief Legal Officer
Eric Siemers
Chief Medical Officer
Jim Doherty
President and Chief Development Officer